Indaptus Corp (INDP) - שולי רווח נקי ממכירות

Indaptus Therapeutics (INDP) generates revenue by creating tumor-activating immunotherapy for medical centers. The net profit margin reflects a turning point driven by a streamlined biomaterials supply chain and temperature control. However, dependence on bacterial platform trials necessitates liquidity management. The value of 0.00 represents the current metric level, capturing the real-time proportion of profit to revenue.
Indaptus Therapeutics - פילוחים אנליטיים ומדדי מפתח (INDP)

The use of external research centers eliminates capital expenditures on production for Indaptus Therapeutics (INDP). Analyzing net margin dynamics allows for an assessment of this model's efficiency. This metric reflects the share of final profit in total revenue after deducting all expenses. It demonstrates the business's ability to generate income amid the rising cost of debt. This enables investors to identify risks of declining capitalization in a timely manner.